Cargando…
The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer
BACKGROUND: The novel sugar transporter and membrane protein SLC50A1 has been identified as a potential candidate biomarker for breast cancer; however, its potential as a serum biomarker for breast cancer detection and prognosis is unclear. The aim of this study was to investigate the serum expressi...
Autores principales: | Wang, Yu, Shu, Yao, Gu, Congyang, Fan, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340503/ https://www.ncbi.nlm.nih.gov/pubmed/30697078 http://dx.doi.org/10.2147/CMAR.S190591 |
Ejemplares similares
-
Diagnostic and prognostic significance of SLC50A1 expression in patients with primary early breast cancer
por: Zhang, Qunchen, et al.
Publicado: (2022) -
Nucleotide Sugar Transporter SLC35 Family Structure and Function
por: Hadley, Barbara, et al.
Publicado: (2019) -
The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Kang, Weiting, et al.
Publicado: (2020) -
Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020) -
Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer
por: Wang, Lu, et al.
Publicado: (2022)